National Philanthropic Trust’s Soleno Therapeutics SLNO Stock Holding History

National Philanthropic Trust’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200,000	Closed	-$6.7M	–	430
2026 Q1	$6.7M	Buy	200,000 +130,455	+188%	+$5.11M	0.07%	76
2025 Q4	$3.22M	Buy	+69,545	New	+$3.81M	0.03%	138

National Philanthropic Trust's SLNO Position: Q2 2026 in Review

National Philanthropic Trust sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 200,000 shares — an estimated $6.7M sold.

National Philanthropic Trust first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $6.7M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

National Philanthropic Trust reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
National Philanthropic Trust sold 200,000 Soleno Therapeutics shares in Q2 2026, an estimated $6.7M.
National Philanthropic Trust first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
National Philanthropic Trust's Soleno Therapeutics position peaked at $6.7M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.